PCOS Women with polycystic ovary syndrome represent one of the populations that may benefit most from retatrutide
The primary endpoint was A1c change
real-world study found users lost about 11.9% of body weight after one year notably less than clinical trial claims
This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
Mechanisms in Bariatric Surgery: Gut Hormones, Diabetes Resolution, and Weight Loss
You can see a full list here , but in our experience, the most common complaints include: Nausea, occasionally leading to periods of vomiting Diarrhea and/or constipation Fatigue Bloating/gas Because these medications require titration (i.e